Clinical trials
Recruiting Heart Failure trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
71 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 2 |
| 2020 | 1 |
| 2021 | 4 |
| 2022 | 2 |
| 2023 | 6 |
| 2024 | 17 |
| 2025 | 16 |
| 2026 | 16 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 71 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 5 |
| Jiangsu Taizhou People's Hospital | 4 |
| Ruijin Hospital | 4 |
| AstraZeneca | 3 |
| Beijing Anzhen Hospital | 2 |
| Beijing Tiantan Hospital | 2 |
| Boehringer Ingelheim | 2 |
| China-Japan Friendship Hospital | 2 |
| Guangdong Provincial People's Hospital | 2 |
| Heart Health Research Center | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Heart Failure | 71 |
| Atrial Fibrillation | 8 |
| Cardiovascular Diseases | 5 |
| Obesity | 4 |
| Arrhythmias, Cardiac | 3 |
| Cardiomyopathy, Dilated | 3 |
| Coronary Disease | 3 |
| Hyperlipidemias | 3 |
| Hypertension | 3 |
| Acute Coronary Syndrome | 2 |
Trials
Showing 1 to 25 of 71. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.